Web This site Trusted
9 result(s) for “okapi bm25 site hotchips pp site github com site of de site huggingface co site:www.owkin.com” · 1033 ms
Scope: Nishi’s own index (our crawl + Common Crawl) — not the whole live web. Some sites block all automated crawlers (anti-bot walls), so their pages may be absent here even though we never filter lawful content.
Freshness: no result on this page carries a fetch time yet (indexed before the fetch epoch was stored beside the doc)
https://www.owkin.com/newsfeed/owkin-unveils-ai-driven-oncology-and-immunology-pipeline-in-licenses-best-in-class-asset-okn4395
to unlock precision drug discovery, development and diagnostics, has unveiled an innovative drug pipeline in oncology and immunology following an exclusive global licensing agreement with Idorsia (SIX: IDIA) to develop and commercialize OKN4395, a clinic-ready best-in-class dual inhibitor of prostanoid receptors EP2
https://www.owkin.com/publications/diagnosis-of-focal-liver-lesions-from-ultrasound-using-deep-learning
Materials and methods
We trained our algorithm on a dataset proposed during a data challenge organized at the 2018 Journées Francophones de Radiologie
https://www.owkin.com/diagnostics/next-gen-ai-dx
clinical routine | Owkin
Owkin Diagnostics is now
Waiv, an Owkin spin-out
Visit wearewaiv.com
Product
AI Scientist
K Pro
The decision-making tool for Pharma
K Pro FAQ
Become a Distribution Partner
Book a Demo
Data
Become a Data Partner
https://www.owkin.com/newsfeed/nhs-trust-and-owkin-to-develop-ai-tool-to-combat-her2-breast-cancer
Thomas Clozel, Co-Founder and CEO of Owkin and former clinical onco-hematologist, said:
While breast cancer treatment has been transformed in recent decades, the disease still takes three quarter of a million lives every year
https://www.owkin.com/a-z-of-ai-for-healthcare/prediction
, co-morbidities) interact to alter risk level
each individual outcome of interest requires a new bespoke-trained model
the range of variables (for example phenotypic, or genetic, or ‘clinical’) that they can handle is limited
https://www.owkin.com/conference-posters/ai-biotech-in-action
WelcomeContent HubOur ScienceOur Team
Our Demos
MOSAIC DatasetK Pro
John Wilbanks
Chief Data Officer
Speaking Engagement
AI Biotech in Action
AI Biotech in Action: How Multimodal Data Is Shaping the Next Generation of Drug Discovery and
https://www.owkin.com/publications/how-to-estimate-the-age-of-your-brain-with-mri-data
Physicians and medical researchers will not become programmers or data scientists overnight, nor will they be replaced by them, but they will need an understanding of what AI actually is and how it works
https://www.owkin.com/faqs/are-external-experts-or-the-academic-community-involved-in-shaping-the-development-of-k-pro
Is the idea of Biological Artificial Superintelligence ethically responsible
https://www.owkin.com/blogs-case-studies/from-banking-to-big-pharma-to-ai-biotech-alban-de-la-sablieres-take-on-jpm-and-industry-trends
The potential of AI to improve all aspects of drug development is now well accepted: there are three main applications: novel target discovery, lead optimization and clinical plan de-risking and acceleration